CA
ZBH icon

CSM Advisors’s Zimmer Biomet ZBH Stock Holding History

CSM Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$730K Buy
8,078
+595
+8% +$54.6K 0.02% 353
2025
Q4 		$672K Buy
7,483
+683
+10% +$64.8K 0.02% 354
2025
Q3 		$670K Buy
6,800
+3,226
+90% +$320K 0.02% 358
2025
Q2 		$326K Buy
+3,574
New +$346K 0.01% 358

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CSM Advisors's ZBH Position: Q1 2026 in Review

CSM Advisors increased its Zimmer Biomet (ZBH) stake by 8% in Q1 2026, buying an estimated $54.6K and bringing the position to 8,078 shares worth $730K. The position accounts for 0.02% of the portfolio, ranked #353.

CSM Advisors first reported a position in ZBH in Q2 2025 and has held it in 4 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • CSM Advisors held 8,078 shares of Zimmer Biomet worth $730K as of Q1 2026.
  • CSM Advisors bought 595 Zimmer Biomet shares in Q1 2026, an estimated $54.6K.
  • Zimmer Biomet made up 0.02% of CSM Advisors's portfolio in Q1 2026, its #353 holding.
  • CSM Advisors first reported a position in Zimmer Biomet in Q2 2025 and has held it in 4 quarters since.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on CSM Advisors's 13F filing for Q1 2026, filed 15 May 2026.